Artificial intelligence is ready to personalise care for people with MS — against

This conference debate made the case against declaring artificial intelligence ready to personalise care for people with multiple sclerosis. The argument was not that AI lacks promise, but that readiness requires evidence beyond technical performance.

The question

Do current AI systems have sufficient clinical evidence, maturity and coverage of the MS pathway to support personalised care now?

Deck outline

• A concise definition of artificial intelligence, machine learning and deep learning
• Diagnosis, prognosis and monitoring as distinct clinical tasks
• The current landscape of AI-based medical devices
• Strengths and limits of brain MRI biomarkers
• Gaps in routine spinal cord analysis
• Clinical utility, implementation evidence and next steps

Take-away

Promising models and accurate image analysis do not by themselves establish personalised care. Readiness means showing benefit in practice, across diverse settings and outcomes that matter to people with MS.